GENFLOW BIOSCIENCES PLC
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
GENF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BP2C3V08
- LEI:
- 213800HVOFXRXVEGDN62
- Country:
- United Kingdom
- Address:
- 6 HEDDON STREET, W1B 4BT LONDON
- Website:
- https://genflowbio.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Genflow Biosciences PLC is a preclinical biotechnology company focused on longevity science. Founded in 2020, the firm develops gene therapies designed to halt or slow the aging process and treat age-related diseases in both humans and dogs. Its core therapeutic approach centers on its lead compound, GF-1002, which delivers a centenarian variant of the SIRT6 gene, a key gene associated with exceptional longevity. The company's mission is to extend healthspan by intervening directly in the biological mechanisms of aging, with its programs demonstrating promising preclinical results.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 11.6 KB | ||
| 2025-10-22 08:00 |
Regulatory News Service
Second European Patent Application
|
English | 17.8 KB | ||
| 2025-10-20 08:00 |
Regulatory News Service
Recognition of Patentability of Claims
|
English | 17.6 KB | ||
| 2025-10-10 08:00 |
Regulatory News Service
Update on Animal Health Program
|
English | 19.0 KB | ||
| 2025-10-09 08:00 |
Share Issue/Capital Change
Update, Equity Issue and PDMR Notification
|
English | 35.1 KB | ||
| 2025-10-02 13:37 |
Share Issue/Capital Change
Issue of Equity - Correction
|
English | 33.2 KB | ||
| 2025-10-02 08:59 |
Director's Dealing
Issue of Equity
|
English | 32.5 KB | ||
| 2025-09-19 13:40 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.0 KB | ||
| 2025-09-19 08:00 |
Regulatory News Service
Genflow Strengthens IP Portfolio
|
English | 16.7 KB | ||
| 2025-09-15 08:00 |
Regulatory News Service
Genflow Signs CDAs with Animal Health Companies
|
English | 17.6 KB | ||
| 2025-08-27 16:07 |
Major Shareholding Notification
Holding(s) in Company
|
English | 21.7 KB | ||
| 2025-08-18 08:00 |
Regulatory News Service
Company Update on Dog Trials
|
English | 19.7 KB | ||
| 2025-07-24 08:00 |
Earnings Release
Clinical Readiness Acceleration
|
English | 17.7 KB | ||
| 2025-07-17 08:00 |
Capital/Financing Update
Genflow Confirms Progression of Grant
|
English | 18.0 KB | ||
| 2025-06-12 11:16 |
Post-Annual General Meeting Information
Result of AGM
|
English | 30.5 KB |
Automate Your Workflow. Get a real-time feed of all GENFLOW BIOSCIENCES PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFLOW BIOSCIENCES PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFLOW BIOSCIENCES PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
